SIRT7 represses Myc activity to suppress ER stress and prevent fatty liver disease J Shin, M He, Y Liu, S Paredes, L Villanova, K Brown, X Qiu, N Nabavi, ... Cell reports 5 (3), 654-665, 2013 | 279 | 2013 |
Effects of microgravity on osteoclast bone resorption and osteoblast cytoskeletal organization and adhesion N Nabavi, A Khandani, A Camirand, RE Harrison Bone 49 (5), 965-974, 2011 | 213 | 2011 |
Long non-coding RNAs in the doxorubicin resistance of cancer cells S Ashrafizaveh, M Ashrafizadeh, A Zarrabi, K Husmandi, A Zabolian, ... Cancer Letters 508, 104-114, 2021 | 142 | 2021 |
Hyaluronic acid-based nanoplatforms for Doxorubicin: A review of stimuli-responsive carriers, co-delivery and resistance suppression M Ashrafizadeh, S Mirzaei, MH Gholami, F Hashemi, A Zabolian, M Raei, ... Carbohydrate polymers 272, 118491, 2021 | 122 | 2021 |
The long and short non-coding RNAs modulating EZH2 signaling in cancer S Mirzaei, MH Gholami, K Hushmandi, F Hashemi, A Zabolian, I Canadas, ... Journal of hematology & oncology 15 (1), 18, 2022 | 114 | 2022 |
Nrf2 signaling pathway in cisplatin chemotherapy: Potential involvement in organ protection and chemoresistance S Mirzaei, AT Mohammadi, MH Gholami, F Hashemi, A Zarrabi, ... Pharmacological research 167, 105575, 2021 | 111 | 2021 |
BAP1 haploinsufficiency predicts a distinct immunogenic class of malignant peritoneal mesothelioma R Shrestha, N Nabavi, YY Lin, F Mo, S Anderson, S Volik, HH Adomat, ... Genome medicine 11, 1-12, 2019 | 105 | 2019 |
Molecular Landscape of LncRNAs in Prostate Cancer: A focus on pathways and therapeutic targets for intervention S Mirzaei, MDA Paskeh, E Okina, MH Gholami, K Hushmandi, M Hashemi, ... Journal of Experimental & Clinical Cancer Research 41 (1), 214, 2022 | 92 | 2022 |
Targeting autophagy in prostate cancer: preclinical and clinical evidence for therapeutic response M Ashrafizadeh, MDA Paskeh, S Mirzaei, MH Gholami, A Zarrabi, ... Journal of Experimental & Clinical Cancer Research 41 (1), 105, 2022 | 92 | 2022 |
Progress in delivery of siRNA-based therapeutics employing nano-vehicles for treatment of prostate cancer M Ashrafizadeh, K Hushmandi, E Rahmani Moghadam, V Zarrin, ... Bioengineering 7 (3), 91, 2020 | 76 | 2020 |
Long non-coding RNAs and exosomal lncRNAs: Potential functions in lung cancer progression, drug resistance and tumor microenvironment remodeling M Entezari, M Ghanbarirad, A Taheriazam, M Sadrkhanloo, A Zabolian, ... Biomedicine & Pharmacotherapy 150, 112963, 2022 | 72 | 2022 |
Targeting MCT 4 to reduce lactic acid secretion and glycolysis for treatment of neuroendocrine prostate cancer SYC Choi, SL Ettinger, D Lin, H Xue, X Ci, N Nabavi, RH Bell, F Mo, ... Cancer medicine 7 (7), 3385-3392, 2018 | 68 | 2018 |
The long noncoding RNA landscape of neuroendocrine prostate cancer and its clinical implications VR Ramnarine, M Alshalalfa, F Mo, N Nabavi, N Erho, M Takhar, ... GigaScience 7 (6), giy050, 2018 | 66 | 2018 |
Gallic acid for cancer therapy: Molecular mechanisms and boosting efficacy by nanoscopical delivery M Ashrafizadeh, A Zarrabi, S Mirzaei, F Hashemi, S Samarghandian, ... Food and Chemical Toxicology 157, 112576, 2021 | 65 | 2021 |
Monocytes from patients with osteoarthritis display increased osteoclastogenesis and bone resorption: the In Vitro Osteoclast Differentiation in Arthritis study M Durand, SV Komarova, A Bhargava, DP Trebec‐Reynolds, K Li, ... Arthritis & Rheumatism 65 (1), 148-158, 2013 | 65 | 2013 |
Dexamethasone: insights into pharmacological aspects, therapeutic mechanisms, and delivery systems VS Madamsetty, R Mohammadinejad, I Uzieliene, N Nabavi, A Dehshahri, ... ACS biomaterials science & engineering 8 (5), 1763-1790, 2022 | 52 | 2022 |
miR-100-5p inhibition induces apoptosis in dormant prostate cancer cells and prevents the emergence of castration-resistant prostate cancer N Nabavi, NRN Saidy, E Venalainen, A Haegert, A Parolia, H Xue, ... Scientific reports 7 (1), 4079, 2017 | 52 | 2017 |
The increased in vitro osteoclastogenesis in patients with rheumatoid arthritis is due to increased percentage of precursors and decreased apoptosis—the In Vitro Osteoclast … M Durand, G Boire, SV Komarova, SJ Dixon, SM Sims, RE Harrison, ... Bone 48 (3), 588-596, 2011 | 50 | 2011 |
Interplay between SOX9 transcription factor and microRNAs in cancer M Ashrafizadeh, A Zarrabi, S Orouei, A Zabolian, H Saleki, N Azami, ... International journal of biological macromolecules 183, 681-694, 2021 | 45 | 2021 |
Pre-clinical investigation of STAT3 pathway in bladder cancer: paving the way for clinical translation S Mirzaei, MH Gholami, MK Mahabady, N Nabavi, A Zabolian, ... Biomedicine & Pharmacotherapy 133, 111077, 2021 | 39 | 2021 |